logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 9
  • 1
    Mr Thomas Flanagan
    Born in October 1947
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2021-03-30
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Trus, Mark
    Individual (1 offspring)
    Officer
    2016-03-22 ~ 2017-04-14
    OF - Secretary → CIF 0
  • 3
    Cash, Kenneth Jason
    Executive Vice President, Finance born in May 1978
    Individual (6 offsprings)
    Officer
    2019-01-03 ~ 2021-10-29
    OF - Director → CIF 0
  • 4
    Flanagan, Patrick
    Born in February 1970
    Individual (6 offsprings)
    Officer
    2016-03-22 ~ now
    OF - Director → CIF 0
    Mr Patrick Flanagan
    Born in February 1970
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ 2021-03-30
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 5
    Ubert, Mark Alan
    Chief Financial Officer born in March 1956
    Individual (6 offsprings)
    Officer
    2017-12-19 ~ 2019-01-03
    OF - Director → CIF 0
  • 6
    Boericke, Kim Mclean
    Born in January 1967
    Individual (1 offspring)
    Officer
    2025-12-31 ~ now
    OF - Director → CIF 0
  • 7
    Bruce, Theresa Margaret
    Vice President, Clinical Operations born in June 1964
    Individual (9 offsprings)
    Officer
    2016-03-22 ~ 2017-12-19
    OF - Director → CIF 0
  • 8
    Henderson, Cynthia
    Born in February 1968
    Individual (6 offsprings)
    Officer
    2021-10-29 ~ 2025-12-31
    OF - Director → CIF 0
  • 9
    ELEMENTAL COMPANY SECRETARY LIMITED
    07900133
    27, Old Gloucester Street, London, United Kingdom
    Active Corporate (5 parents, 550 offsprings)
    Officer
    2017-04-14 ~ now
    OF - Secretary → CIF 0
parent relation
Company in focus

VERISTAT INTERNATIONAL LIMITED

Period: 2016-03-22 ~ now
Company number: 10076882
Registered name
VERISTAT INTERNATIONAL LIMITED - now
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Intangible Assets
Other
39,647 GBP2023-12-31
350,051 GBP2022-12-31
Property, Plant & Equipment
59,074 GBP2023-12-31
99,995 GBP2022-12-31
Fixed Assets - Investments
14,774,955 GBP2023-12-31
23,167,346 GBP2022-12-31
Fixed Assets
14,873,676 GBP2023-12-31
23,617,392 GBP2022-12-31
Debtors
8,018,470 GBP2023-12-31
26,000,379 GBP2022-12-31
Cash at bank and in hand
1,118,434 GBP2023-12-31
656,631 GBP2022-12-31
Current Assets
9,136,904 GBP2023-12-31
26,657,010 GBP2022-12-31
Net Current Assets/Liabilities
-4,287,498 GBP2023-12-31
-6,005,077 GBP2022-12-31
Total Assets Less Current Liabilities
10,586,178 GBP2023-12-31
17,612,315 GBP2022-12-31
Net Assets/Liabilities
10,577,207 GBP2023-12-31
17,516,002 GBP2022-12-31
Equity
Called up share capital
200 GBP2023-12-31
200 GBP2022-12-31
100 GBP2021-12-31
Share premium
12,954,535 GBP2023-12-31
12,954,535 GBP2022-12-31
0 GBP2021-12-31
Retained earnings (accumulated losses)
-2,377,528 GBP2023-12-31
4,561,267 GBP2022-12-31
1,636,847 GBP2021-12-31
Equity
10,577,207 GBP2023-12-31
17,516,002 GBP2022-12-31
294,762 GBP2021-12-31
Profit/Loss
-6,938,795 GBP2023-01-01 ~ 2023-12-31
2,924,420 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
Called up share capital
100 GBP2022-01-01 ~ 2022-12-31
Issue of Equity Instruments
12,954,635 GBP2022-01-01 ~ 2022-12-31
Average Number of Employees
862023-01-01 ~ 2023-12-31
1372022-01-01 ~ 2022-12-31
Wages/Salaries
5,002,667 GBP2023-01-01 ~ 2023-12-31
4,919,330 GBP2022-01-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
288,061 GBP2023-01-01 ~ 2023-12-31
277,806 GBP2022-01-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
5,883,241 GBP2023-01-01 ~ 2023-12-31
5,755,582 GBP2022-01-01 ~ 2022-12-31
Intangible Assets - Gross Cost
Development expenditure
568,168 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
528,521 GBP2023-12-31
218,117 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Development expenditure
211,675 GBP2023-01-01 ~ 2023-12-31
Intangible Assets
Development expenditure
39,647 GBP2023-12-31
350,051 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
100,563 GBP2023-12-31
99,995 GBP2022-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-14,899 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
41,489 GBP2023-12-31
0 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
41,489 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
Plant and equipment
59,074 GBP2023-12-31
99,995 GBP2022-12-31
Investments in Subsidiaries
14,774,955 GBP2023-12-31
23,167,346 GBP2022-12-31
Trade Debtors/Trade Receivables
874,301 GBP2023-12-31
1,051,501 GBP2022-12-31
Amount of corporation tax that is recoverable
62,926 GBP2023-12-31
0 GBP2022-12-31
Other Debtors
Current
0 GBP2023-12-31
2,382 GBP2022-12-31
Prepayments/Accrued Income
Current
1,354,214 GBP2023-12-31
5,909,627 GBP2022-12-31
Corporation Tax Payable
Current
0 GBP2023-12-31
109,295 GBP2022-12-31
Other Creditors
Current
825,333 GBP2023-12-31
1,036,594 GBP2022-12-31
Intangible Assets
9,367,331 GBP2022-12-31
Related profiles found in government register
  • VERISTAT INTERNATIONAL LIMITED
    Info
    Registered number 10076882
    27 Old Gloucester Street, London WC1N 3AX
    PRIVATE LIMITED COMPANY incorporated on 2016-03-22 (10 years). The company status is Active.
    The last date of confirmation statement was made at 2025-03-22
    CIF 0
  • VERISTAT INTERNATIONAL LIMITED
    S
    Registered number 10076882
    27, Old Gloucester Street, London, England, WC1N 3AX
    Private Limited Company in Companies House, United Kingdom
    CIF 1
    Private Limited Company in Registrar Of Companies, England
    CIF 2
  • VERISTAT INTERNATIONAL LIMITED
    S
    Registered number 10076882
    27, Old Gloucester Street, London, United Kingdom, WC1N 3AX
    Private Limited Company in Companies House, England
    CIF 3
(more)
child relation
Offspring entities and appointments 4
  • 1
    SFL REGULATORY AFFAIRS CONSULTING LTD
    06795068
    27 27 Gloucester Street, London, England
    Active Corporate (5 parents)
    Person with significant control
    2022-02-25 ~ now
    CIF 3 - Right to appoint or remove directors → OE
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
  • 2
    SQN CLINICAL LIMITED
    06926512
    27 Old Gloucester Street, London, England
    Dissolved Corporate (7 parents, 1 offspring)
    Person with significant control
    2021-02-18 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
  • 3
    SYNE QUA NON LIMITED
    03148610
    27 Old Gloucester Street, London, England
    Active Corporate (10 parents)
    Person with significant control
    2023-04-12 ~ now
    CIF 4 - Ownership of shares – 75% or more → OE
  • 4
    THE CLINICAL TRIAL COMPANY LTD
    04372093
    27 Old Gloucester Street, London, England
    Dissolved Corporate (10 parents)
    Person with significant control
    2019-12-31 ~ dissolved
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.